share_log

Market-Moving News for May 21st

Market-Moving News for May 21st

5月21日的市场动向新闻
Benzinga ·  05/21 08:42

BDRX: 110% | Biodexa Pharmaceuticals Presents Phase 2 Clinical Trial Results Of Its Newly-Licensed eRapa In Familial Adenomatous Polyposis Scheduled For Presentation At The 2024 Digestive Disease Week Annual Meeting; Reports Overall 83% Non-Progression Rate At 6 Months

BDRX:110% | Biodexa Pharmicals公布了其新获得许可的家族性腺瘤性息肉病eRapa的2期临床试验结果,该结果计划在2024年消化系统疾病周年会上公布;报告称,6个月的总体非进展率为83%

MMAT: 95% | Meta Materials shares are trading higher after the company announced that lawyers concluded that it has meritorious claims for market manipulation against several parties.

MMAT:95% | Meta Materials的股价走高,此前该公司宣布律师得出结论,对多方提出了合理的市场操纵指控。

SPT: -11% | Sprout Social shares are trading lower after the company said there is no process in place to sell or take the Company private.

SPT:-11% | Sprout Social的股价走低,此前该公司表示尚未制定出售或私有化的程序。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发